Human cell line derived from Wilms' tumor. Expressing CA125 and TPA.
Comment from the depositor
Terms and conditions
Need an approval of the approver. Academic basic research purpose only (excluding any type of commercial use, i.e., commercializing not only HFWT cells but also all the HFWT-originated commercially useful materials and methods such as the cellular components, products, genes, their derivatives, application methods, and the like.) .
Cell-Medicine, Inc. Headquater 2-1-6 Sengen, Tsukuba, Ibaraki 305-0047 Japan
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (firstname.lastname@example.org).
Ishiwata I, Ono I, Ishiwata C, Soma M, Nakaguchi T, Ohara K, Hirano M, Ishikawa H
Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivo.Exp Pathol
PubMed ID: 1850701
Zhu Q, Zhan D, Yang Y, Chong Y, Xue H, Zhu P.
LINC00173 Promotes Wilms' Tumor Progression Through MGAT1-mediated MUC3A N-glycosylation.Cell Cycle
PubMed ID: 35491865
Zhu S, Zhang J, Gao X, Tang X, Cui Y, Li D, Jia W.
Silencing of long noncoding RNA MYLK-AS1 suppresses nephroblastoma via down-regulation of CCNE1 through transcription factor TCF7L2.J Cell Physiol
PubMed ID: 33438217
Zhu S, Zhang J, Cui Y, Tang X, Gao X, Li D, Jia W.
Long non-coding RNA HOXA11-AS upregulates Cyclin D2 to inhibit apoptosis and promote cell cycle progression in nephroblastoma by recruiting forkhead box P2.Am J Cancer Res
PubMed ID: 32064168
Harada H, Watanabe S, Saijo K, Ishiwata I, Ohno T
A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.Exp Hematol
PubMed ID: 15246157